13F Data
13F filer · CIK 1263048

MPM ASSET MANAGEMENT LLC

BOSTON, MA · filing since Q2 2013 · last filing Nov 14, 2025
Reported value
$44.5M
+$1.2M vs prior
Positions
4
New / sold out
0 / 1
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $1.2M
Top-10 weight
100.0%

Biggest buys vs Q2 2025

No new or increased positions this quarter.

Biggest sells vs Q2 2025

ChangeSecurityShares changeChange %Est. trade value
Sold outAdaptimmune Therapeutics plc-4,809,677-100.0%$-1.2M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $225.9MQ3 2013: $354.6MQ4 2013: $309.6MQ1 2014: $236.3MQ2 2014: $297.3MQ3 2014: $305.6MQ4 2014: $450.3MQ1 2015: $468.9MQ2 2015: $597.6MQ3 2015: $650.0MQ4 2015: $560.4MQ1 2016: $322.7MQ2 2016: $308.3MQ3 2016: $305.3MQ4 2016: $211.9MQ1 2017: $207.9MQ2 2017: $230.2MQ3 2017: $204.9MQ4 2017: $249.5MQ1 2018: $259.6MQ2 2018: $258.2MQ3 2018: $147.7MQ4 2018: $118.2MQ1 2019: $242.5MQ2 2019: $247.5MQ3 2019: $233.7MQ4 2019: $227.2MQ1 2020: $164.4MQ2 2020: $336.1MQ3 2020: $536.3MQ4 2020: $706.6MQ1 2021: $517.6MQ2 2021: $537.9MQ3 2021: $431.5MQ4 2021: $462.7MQ1 2022: $292.6MQ2 2022: $237.0MQ3 2022: $262.6MQ4 2022: $239.0MQ1 2023: $240.0MQ2 2023: $203.9MQ3 2023: $186.7MQ4 2023: $203.5MQ1 2024: $245.2MQ2 2024: $182.1MQ3 2024: $145.3MQ4 2024: $124.4MQ1 2025: $69.4MQ2 2025: $43.3MQ3 2025: $44.5M
Q2 2013Q3 2025

Holdings · Q3 2025

#SecuritySharesValueWeight
1Entrada Therapeutics, Inc.COMMON4,381,062$25.4M57.09%
2Dyne Therapeutics, Inc.COMMON682,376$8.6M19.40%
3Werewolf Therapeutics, Inc.COMMON4,309,860$8.5M19.08%
4Repare Therapeutics, Inc.COMMON1,121,318$2.0M4.43%